{"id":10007,"date":"2026-05-22T01:30:00","date_gmt":"2026-05-21T23:30:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=c4eac0ffd85a4b6f337086ca62a4d6d6"},"modified":"2026-05-22T01:30:00","modified_gmt":"2026-05-21T23:30:00","slug":"phibro-animal-health-corporation-to-participate-in-stifel-jaws-paws-conference","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=10007","title":{"rendered":"Phibro Animal Health Corporation to Participate in Stifel Jaws &amp; Paws Conference"},"content":{"rendered":"<p>TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Stifel Jaws &amp; Paws Conference.<\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260521172103\/en\/1872586\/5\/New_PNG_Phibro_AnimalHealthCorporation_Color_RGB_R.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260521172103\/en\/1872586\/22\/New_PNG_Phibro_AnimalHealthCorporation_Color_RGB_R.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260521172103\/en\/1872586\/5\/New_PNG_Phibro_AnimalHealthCorporation_Color_RGB_R.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260521172103\/en\/1872586\/21\/New_PNG_Phibro_AnimalHealthCorporation_Color_RGB_R.jpg\" \/><\/a><p>\nExecutive Vice President, Corporate Strategy &amp; CEO Designate, Daniel Bendheim; Chief Operating Officer, Larry Miller; and Chief Financial Officer, Glenn David will address financial analysts and investors on Wednesday, May 27, 2026, at 9:45 AM ET at Lotte New York Palace in New York.<\/p><p>\nThe live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.pahc.com&amp;esheet=54540278&amp;newsitemid=20260521172103&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.pahc.com&amp;index=1&amp;md5=3e15bd70ff58cc10edeba561e195455b\" rel=\"nofollow\" shape=\"rect\">https:\/\/investors.pahc.com<\/a>. A replay of the session will be available and archived on the company\u2019s website.<\/p><p>\n<b>About Phibro Animal Health Corporation<\/b><\/p><p>\nPhibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians, and consumers who raise or care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. For further information, please visit <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.pahc.com&amp;esheet=54540278&amp;newsitemid=20260521172103&amp;lan=en-US&amp;anchor=www.pahc.com&amp;index=2&amp;md5=d681c7beee1e80336d90274bb833d1a2\" rel=\"nofollow\" shape=\"rect\">www.pahc.com<\/a>.<\/p><p>\nOur filings with the Securities and Exchange Commission are available online at <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=54540278&amp;newsitemid=20260521172103&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=3&amp;md5=7782a6d2c0edbefc7d8490b65174a6dc\" rel=\"nofollow\" shape=\"rect\">www.sec.gov<\/a>, <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.pahc.com&amp;esheet=54540278&amp;newsitemid=20260521172103&amp;lan=en-US&amp;anchor=www.pahc.com&amp;index=4&amp;md5=c6cafa4a3743872bce6bab3f54aaa92f\" rel=\"nofollow\" shape=\"rect\">www.pahc.com<\/a> or on request from the company.<\/p><br\/> <b>Contacts<\/b> <br\/><p>\nGlenn C. David\n<br\/>Chief Financial Officer, Phibro Animal Health Corporation\n<br\/>+1-201-329-7300\n<br\/><a  href=\"mailto:investor.relations@pahc.com\" rel=\"nofollow\" shape=\"rect\">investor.relations@pahc.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>TEANECK, N.J.&#8211;(BUSINESS WIRE)&#8211;Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Stifel Jaws &amp; Paws Conference.<br \/>\nExecutive Vice President, Corporate Strategy &amp; CEO Designate, Daniel Bendheim; Chief Opera&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10007","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/10007","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=10007"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/10007\/revisions"}],"predecessor-version":[{"id":10008,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/10007\/revisions\/10008"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=10007"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=10007"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=10007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}